Pirfenidone

MedicationExperimental0 reviews

—

Average score out of 5

Experimental — This treatment is under research. Available data is limited. Consult your doctor before making any decision.

Pirfenidone is a medication used to treat idiopathic pulmonary fibrosis (IPF). It is being investigated for Long COVID due to its antifibrotic properties, particularly in patients with persistent lung problems.

Information

Subcategory: antifibrotic and anti-inflammatory agent
Evidence level: 2/5
Evidence type: preliminary clinical trials on post-COVID lung sequelae

Share your experience

Your feedback helps thousands of people find what really works.

Join the community